Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Show me how to use this page

Lava Therapeutics B.v. Stock

Price
Target price
€1.64

€1.64

1.210%
0.02
1.210%
€6.00
 
20.08.24 / Tradegate WKN: A2QSJY / Name: Lava Therapeutics B.v. / Stock / ? /
Please give a prediction to see the opinions of the community
Buy
None
Sell
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Lava Therapeutics B.v. in the next few years
Wizard

Lava Therapeutics B.v. Stock

Lava Therapeutics B.v. gained 1.210% today.
The community is currently still undecided about Lava Therapeutics B.v. with 1 Buy predictions and 1 Sell predictions.
With a target price of 6 € there is potential for a 265.85% increase which would mean more than doubling the current price of 1.64 € for Lava Therapeutics B.v..
Our community identified positive and negative aspects for Lava Therapeutics B.v. stock for the coming years. 3 users see the criterium "Worthwhile Investment for the next years" as a plus for the Lava Therapeutics B.v. stock. On the other hand our users think that "Unique positioning" could be a problem in the future.
What does Lava Therapeutics B.v. do?

Pros and Cons of Lava Therapeutics B.v. in the next few years

Pros
?
B****
?
S********** s********
?
C******** o* t** e**********
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Your Opinion
Legal notice

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2024-08-01

Lava Therapeutics B.V. has made a niche for itself in the biotechnology industry, and an examination of its financials reveals a company that is currently navigating through some choppy waters. With a market capitalization of approximately $48.9 million, financial metrics such as a negative EBITDA and profit margins indicate that the company is still in the developmental stage, working towards profitability. While the existence of certain positive growth indicators hints at potential, the overall picture may raise concerns for prudent investors.

Market Growth Potential: The biotechnology sector is known for its rapid advancements and market opportunities. As a company operating in this space, Lava Therapeutics has the potential to capitalize on emerging therapeutics that could significantly improve its financial situation in the future.

Revenue Growth: Despite overall losses, the firm showcases a quarterly revenue growth of 4.71% year over year. This could signal increasing interest in its products or services, suggesting that the company is moving in the right direction.

Show more
Register To Post